Other

This correspondence provides updates on the May 2023 Xylazine Exposure Guidance and discusses implications for clinical practice and frontline public health.

This bulletin encourages states to to consider leveraging available Medicaid and Children’s Health Insurance Program (CHIP) opportunities to improve access to mental health (MH) and substance use disorder (SUD) services for individuals experiencing homelessness.

The dashboard reviews tobacco use in the United States. It provides state-level data and emphasizes disparities.

The 988 Lifeline publishes and regularly updates a 988 Partner Toolkit, which provides partners social media, video, print, radio, FAQs, messaging, and other marketing materials that can be used to promote the 988 Suicide & Crisis Lifeline. These 988 Suicide & Crisis Lifeline print materials are free to the public.

This resource provides a glossary of terms for healthcare professionals to familiarize themselves with when treating members of the LGBTQ+ community.

These slides focus on substance use and mental health measures for several sub-populations in the United States, including American Indian and Alaska Native; Asian; Black or African; Female; Hispanic or Latino; Lesbian, Gay, or Bisexual Adult; Multiracial; Native Hawaiian and Other Pacific Islander; and Veteran populations.

This dashboard presents data from the CDC's State Unintentional Drug Overdose Reporting System (SUDORS), which collects data on unintentional and undetermined intent drug overdose deaths.

These FAQs provide clarification regarding federal policy on coverage of peer support services.

These are slides from a 2019 presentation on the results of a low barrier buprenorphine pilot program conducted by the San Francisco Department of Public Health.

This is the press packet for Project ECHO, a joint 12-month Project ECHO on implementation of a low barrier treatment model for opioid use disorder. It describes the plan and background of the project, and the pieces that makle a low-barrier model unique.